Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Urologic Health has secured $11 million in seed funding to advance its catheter-free bladder function monitoring system and prepare for U.S. market entry.
InsideTracker has launched Terra, a neurosymbolic AI platform designed to help wellness businesses deliver individualized, evidence-based health guidance at scale. The system integrates multiple health data sources to generate transparent, science-backed recommendations.
Enlil reported a record first quarter of 2026, securing eight new MedTech customers who adopted its AI-powered traceability platform after moving away from legacy quality and product lifecycle systems.
Saile has raised $2.2 million in an oversubscribed pre-seed round led by Matchstick Ventures to improve healthcare staffing and credentialing. The platform uses AI agents to automate recruitment, onboarding, and compliance across various care settings.
EMA Wellness has formed an exclusive partnership with Mira Analytics to apply AI models for endpoint validation and rater surveillance in global central nervous system clinical trials, integrating these capabilities into EMAW's data platform.
Minset announced that its autonomous medical coding system, mCoder, achieved state-of-the-art results on the MDACE benchmark, surpassing all prior peer-reviewed results across both constrained and full-label evaluations.
Supreme Group has launched Supreme Intelligence FDE+, described as the first Forward Deployed Expert model designed specifically for healthcare and life sciences. The model integrates domain expertise with the Supreme Intelligence platform to deliver custom AI solutions for clients in regulated medical fields.
German pharmaceutical company CHEPLAPHARM has implemented TraceLink's Multienterprise Information Network Tower (MINT) to automate and standardize its global supply chain operations, enabling real-time data exchange and improved efficiency across its partner network.
Hippocratic AI has announced six senior executive appointments to strengthen its leadership across strategy, legal, revenue, communications, and customer success functions as it scales its healthcare AI platform.
Zifo has launched an AI enabled data migration solution that automates complex scientific data transfers while maintaining compliance and validation for industries such as biopharma.
Datar Cancer Genetics has received U.S. FDA clearance for its CellDx Tissue assay, a comprehensive genomic profiling test for solid tumors that analyzes DNA and RNA to identify key cancer-related genetic variations.
Ozelle received the German Innovation Award Gold for its EHBT-50 Mini Lab, a multifunctional diagnostic system that integrates hematology, biochemistry, immunoassay, and AI-assisted morphology analysis into one platform designed for decentralized clinical environments.
Varda Space Industries and United Therapeutics have announced a collaboration to study drug formulation in microgravity, aiming to develop improved treatments for rare pulmonary diseases using Varda's orbital manufacturing platform.
The American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator have launched CGTxchange, an AI-enhanced marketplace designed to reactivate promising but shelved cell and gene therapy programs. The platform is live with pilot assets and now accepting applications from sponsors.
Cantex Pharmaceuticals and Headlamp Health have announced a partnership to use Headlamp's Lumos AI platform to accelerate the development of azeliragon for treating severe depression and fatigue in multiple sclerosis patients.
Global Healthcare Exchange (GHX) has introduced a new AI-powered orchestration layer to help healthcare providers and suppliers detect disruptions earlier and coordinate faster across supply chain workflows. The launch was announced at the GHX Summit in New Orleans.
Natus Medical Incorporated has established a Global EEG Advisory Board composed of clinical experts to advise on product development, AI integration, and workflow improvements in neurodiagnostics.
Corti has launched a Startup Acceleration Program to help healthcare AI founders address regulatory and technical challenges in Europe and the U.S. The program offers access to Corti’s clinical-grade Symphony models and regulatory guidance for startups worldwide.
SOPHiA GENETICS has partnered with Synnovis to introduce liquid biopsy testing for lung and breast cancer patients across the UK, supporting NHS England's new blood test-first program.
Cellular Intelligence has obtained global rights to Novo Nordisk's clinical-stage Parkinson's cell therapy and will apply its AI platform to accelerate development and manufacturing, while Novo Nordisk takes an equity stake.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
